CHDN Refinances with New $500M Term Loan B, Extending Maturities but Adding Leverage

What happened

Churchill Downs has completed an amended and extended credit agreement for its revolver and term loan A facility, and issued a new $500 million institutional term loan B. The press release offers no details on use of proceeds, pricing, or covenants, but the move comes when the company already carries net debt of $4.74 billion, net debt-to-EBITDA of 4.44x, and interest coverage of 2.33x, following a BB- downgrade from S&P. While extending maturities may reduce near-term refinancing risk, adding a term loan B typically increases total funded debt unless it concurrently retires existing obligations, and management has not clarified whether the new debt is incremental. This financing action appears inconsistent with management's stated goal of reducing bank covenant net leverage below 4.0x during 2026, and it may further strain interest coverage. Without explicit disclosure that the proceeds are being used to repay higher-cost debt or that the facility amendment includes covenant relief, investors should treat the announcement as a modest negative for the balance-sheet trajectory.

Implication

Investors should request clarity on whether the $500 million term loan B is incremental or a refinancing of existing maturities, because incremental debt would push net debt-to-EBITDA above 4.6x absent EBITDA growth. The move may extend the company's debt maturity profile and provide liquidity, but it does not address the core operating issue: sluggish Virginia HRM ramp and heavy capital returns continue to offset cash generation. The financing reinforces the S&P view that Churchill Downs is comfortable operating with elevated leverage, which could lead to further rating pressure and higher borrowing costs. Until management confirms that 2026 capex guidance and buyback restraint remain intact, the risk of covenant breach or forced capital allocation changes increases. Near-term, the stock may react negatively to the perceived deleveraging delay, and we maintain our WAIT rating with a preference for waiting for FY2025 results and management commentary before adding exposure.

Thesis delta

The thesis previously conditioned upside on capex normalization driving net leverage below 4.0x by 2026. The new $500 million term loan B, if incremental, directly raises debt and pushes the deleveraging timeline further out, undermining that pillar. We now require explicit disclosure that the TLB is part of a maturity extension and not an increase in net debt; otherwise, our conviction in the base case decreases and we lower our entry threshold.